Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease

Award Number: R01AG054057
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2016
PERIOD OF PERFORMANCE END DATE: 12/31/2026

Group Awards By:

View Award Description

Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease - PROJECT SUMMARY The project Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease (RF1AG054057) demonstrated for the first time that pro-oxidant iron directly measured in human brain is strongly associated with cognitive decline in older persons with AD pathology. In this proposed continuation, we propose to further these studies to resolve mechanisms underlying brain iron elevation, susceptibility to iron-mediated damage, and resultant decline. Underpinning our hypothesis is the recently discovered programmed death pathway, ferroptosis, which causes destruction of synaptic and cellular membranes by iron dependent peroxidation of certain lipids. Strong preliminary data supports these aims. In this competive renewal, we propose to test the hypotheses that (1) dietary fat and brain lipids contribute to the elevation of brain iron; and (2) iron interacts with brain lipids to promote lipid peroxidation, resulting in toxic brain injury (via ferroptosis), neuronal loss, and ultimately accelerated cognitive and motor decline in aging. We propose to use novel methodologies, incorporating (oxidized) lipidomics using advanced methodologies (i.e. targeted and oxidized lipidomics and immune-assisted, tandem Laser Ablation MALDI/ICP-MS) to map iron and lipid-mediated neurodegeneration in cognitive and motor brain regions. We will expand dietary studies, and leverage a rich resource of clinical and pathologic data available from Rush Memory and Aging Project. Overall, we propose to collect new data on brain lipids, increase data on iron and dietary fats to goal of 850 brains. In Aim 1, we will test the hypotheses that dietary fat intake is associated with brain lipid composition and iron content; that brain lipid composition is associated with brain iron content; and use advanced technology to map and test their relationship across the layered cortex. In Aim 2, we propose to detect oxidized lipids and test the hypotheses that lipid peroxidation is associated with brain iron, Alzheimer’s pathology, and cognitive decline. We also will investigate whether lipid peroxides mediate cognitive decline associated with iron in AD. In Aim 3 we will determine brain iron and (oxidized) lipid content in brain motor regions and test the hypothesis that regional brain iron is associated with lipid composition and with motor function and decline and motor pathology (Lewy body, vascular, AD, etc.) in older persons. In each aim, we will investigate how relationships differ by APOE ε4, Alzheimer’s pathologic diagnosis and sex. Overall, these studies have the potential to uncover new mechanisms by which iron, lipids (diet and brain), and APOE ε4 increase cognitive and motor decline in aging and AD. These studies have the potential to reveal new and targetable biologic pathways.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $589,021 )
2026	2026	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	000	6	2/5/2026	NON-COMPETING CONTINUATION	$530,119
2026	2026	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	001	6	2/23/2026	NON-COMPETING CONTINUATION	$58,902
														Subtotal = $589,021

Issue Date FY: 2025 ( Subtotal = $575,769 )
2025	2025	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	001	5	9/3/2025	NON-COMPETING CONTINUATION	$47,000
2025	2025	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	000	5	12/4/2024	NON-COMPETING CONTINUATION	$528,769
														Subtotal = $575,769

Issue Date FY: 2024 ( Subtotal = $597,000 )
2024	2024	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	000	4	12/11/2023	NON-COMPETING CONTINUATION	$537,301
2024	2024	RUSH UNIVERSITY MEDICAL CENTER	1653 W CONGRESS PKWY	CHICAGO	IL	60612	COOK	USA	Aging Research	001	4	7/1/2024	NON-COMPETING CONTINUATION	$59,699
														Subtotal = $597,000

Issue Date FY: 2023 ( Subtotal = $602,400 )
2023	2023	RUSH UNIVERSITY MEDICAL CENTER	1620 W HARRISON ST	CHICAGO	IL	60612	COOK	USA	Aging Research	000	3	1/6/2023	NON-COMPETING CONTINUATION	$602,400
														Subtotal = $602,400

Issue Date FY: 2022 ( Subtotal = $611,019 )
2022	2022	RUSH UNIVERSITY MEDICAL CENTER	1620 W HARRISON ST	CHICAGO	IL	60612	COOK	USA	Aging Research	000	2	4/6/2022	COMPETING CONTINUATION	$611,019
														Subtotal = $611,019

Grand Total All Awards = $2,975,209

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's Disease

Award Number: R01AG054057

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2016

PERIOD OF PERFORMANCE END DATE: 12/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer